Detection of glyco‐mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours

The CA125 assay detects circulating MUC16 and is one of the most widely used cancer biomarkers for the follow‐up of ovarian cancer. We previously demonstrated that detection of aberrant cancer‐associated glycoforms of MUC16 as well as MUC1 in circulation could improve the yield of these serum assays...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Oncol
Главные авторы: Ricardo, Sara, Marcos-Silva, Lara, Pereira, Daniela, Pinto, Rita, Almeida, Raquel, Söderberg, Ola, Mandel, Ulla, Clausen, Henrik, Felix, Ana, Lunet, Nuno, David, Leonor
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2014
Предметы:
Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528651/
https://ncbi.nlm.nih.gov/pubmed/25454345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.10.005
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы